Be the first to like.


On Wednesday, March 27, 2:00-3:30 pm, the National Academy of Medicine and the CSIS Commission on Strengthening America’s Health Security hosted a conversation on the unfolding debate as to whether human germline genome editing should be permitted, the types of applications which might be appropriate, the standards and criteria that should be followed, and what regulatory or governance framework is needed.


Dr. Victor Dzau
President, National Academy of Medicine

Tim Hunt
Senior Vice President, Corporate Affairs, Editas Medicine

Jeffrey Kahn
Andreas C. Dracopoulos Director, Johns Hopkins Berman Institute of Bioethics

Anne-Marie Mazza
Senior Director, Committee on Science, Technology, and Law, The National Academies of Sciences, Engineering, and Medicine

Moderated by

J. Stephen Morrison
Senior Vice President and Director, CSIS Global Health Policy Center

…continue reading ‘Post-Hong Kong: Human Genome Editing’s Brave New World’

Be the first to like.


Tags: , , , , , , , , , , , ,

Leave a Reply